Think of Recarbrio as Similar to Avycaz and Vabomere

February 2020

Recarbrio (reh-CAR-bree-oh, imipenem/cilastatin/relebactam) will be a new "carbapenem/beta-lactamase inhibitor" antibiotic combo.

Think of it as an alternative to Vabomere (meropenem/vaborbactam) and Avycaz (ceftazidime/avibactam).

Recarbrio's claim to fame is that relebactam helps imipenem/cilastatin (Primaxin) outsmart some bacteria that would otherwise be resistant.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Practice Prevent Common Issues With Med Delivery
Infectious Diseases Think of Recarbrio as Similar to Avycaz and Vabomere
Heart Failure Keep Meds for "LVAD" Patients Straight
CPR Avoid Mishaps if Your Pharmacy Stocks Bretylium
Seizures Anticipate Treating Seizures Fast With IV Levetiracetam
Parkinson's Disease Nourianz Will Be a New Add-On for Parkinson's
Med Administration Gather Info to Guide Redosing of a Med After Vomiting
Cystic Fibrosis Expect Trikafta for Cystic Fibrosis to Be Continued In-House
Emergency Medicine Expedite Treatment for Stimulant Overdoses